These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 26123090
1. Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma. van Dijk EH, van Herpen CM, Marinkovic M, Haanen JB, Amundson D, Luyten GP, Jager MJ, Kapiteijn EH, Keunen JE, Adamus G, Boon CJ. Ophthalmology; 2015 Sep; 122(9):1907-16. PubMed ID: 26123090 [Abstract] [Full Text] [Related]
2. Subretinal Fluid Associated With MEK Inhibitor Use in the Treatment of Systemic Cancer. Weber ML, Liang MC, Flaherty KT, Heier JS. JAMA Ophthalmol; 2016 Aug 01; 134(8):855-62. PubMed ID: 27309887 [Abstract] [Full Text] [Related]
11. Near-infrared fundus autofluorescence in subclinical best vitelliform macular dystrophy. Parodi MB, Iacono P, Del Turco C, Bandello F. Am J Ophthalmol; 2014 Dec 01; 158(6):1247-1252.e2. PubMed ID: 25174897 [Abstract] [Full Text] [Related]
12. Ocular Toxicity in Metastatic Melanoma Patients Treated With Mitogen-Activated Protein Kinase Kinase Inhibitors: A Case Series. Niro A, Strippoli S, Alessio G, Sborgia L, Recchimurzo N, Guida M. Am J Ophthalmol; 2015 Nov 01; 160(5):959-967.e1. PubMed ID: 26231307 [Abstract] [Full Text] [Related]